No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract Multiple Cereblon genetic alterations were associated with acquired resistance to lenalidomide or pomalidomide in multiple myeloma

byKathleen Lau

February 11, 2021

in StudyGraphics

Long-term usage of cyproterone acetate (CPA) at high doses associated with greater risk of meningioma development in females

RelatedReports

Lessons from real-world implementation of lung cancer screening

AI Roundup

Sacituzumab tirumotecan may have a role in the treatment of metastatic non-small cell lung cancer

June 10, 2025

Pharma

2 Minute Medicine: Pharma Roundup – Perioperative Immunotherapy Efficacy, Expanded Prostate Cancer Indication, Rapid Subcutaneous Myeloma Administration, and Regulatory Compliance Findings [June 4 2025]

June 4, 2025

New genetic link in pulmonary arterial hypertension holds therapeutic promise

Chronic Disease

Hereditary erythrocytosis is associated with a fetal-like EPO isoform

June 2, 2025

AI Roundup

Physical disability and psychological distress demonstrate marked progression after diagnosis of cancer

May 28, 2025

#VisualAbstract: Endocrine therapy plus oral S-1 improves invasive disease-free survival in patients with ER⁺ breast cancer

#VisualAbstract: BRAF/MEK inhibitor therapy may be associated with risk of uveitis in patients with advanced melanoma

Preterm infants responsive to PCV13 vaccine

Increasing vaccine coverage in low and middle-income countries may prevent over 30 million deaths between 2020 to 2030

Complement mutation linked to poor response to eculizumab

Acute neurologic manifestations in children with hemolytic uremic syndrome linked to increased mortality

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports